Predictors of gastrointestinal bleeding in patients following left ventricular assist device implantation: a systematic review and meta-analysis.

Aim: Our study aims to provide a more holistic understanding of the available data and predictive risk factors for gastrointestinal bleed (GIB). Materials & methods: We searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials and Web of Science Core Collection and calculated relative risk and meta-regression was utilized to evaluate for risk factors in order to assess the effect of covariates. Results: Our meta-analysis reported a pooled prevalence rate of GIB of 24.4%. Meta-regression analysis did not yield a statistically significant association between GIB and risk factors, including age, gender, hypertension, chronic kidney disease and diabetes. Conclusion: Studies investigating larger sample sizes are required for conclusive findings.

[1]  Y. Toyoda,et al.  Shared Care to Destination Therapy Left Ventricular Assist Device Site: a Novel Strategy to Start a Successful Mechanical Circulatory Support Program , 2021, Current Cardiology Reports.

[2]  R. Khorshid,et al.  LEFT VENTRICULAR ASSIST DEVICE THERAPY IN HEART FAILURE: A META-ANALYSIS , 2021 .

[3]  V. Kaul,et al.  Primary and Secondary Prevention Strategies for Gastrointestinal Bleeding in Patients with Left Ventricular Assist Device: A Systematic Review and Network Meta-analysis. , 2021, Current problems in cardiology.

[4]  S. Aggarwal,et al.  Characterization and timing of gastrointestinal bleeding in continuous flow left ventricular assist device recipients , 2020, Heliyon.

[5]  H. Eisen.  Left Ventricular Assist Devices (LVADS): History, Clinical Application and Complications , 2019, Korean circulation journal.

[6]  Axel Haverich,et al.  Five-year results of patients supported by HeartMate II: outcomes and adverse events , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  J. Moake,et al.  Acquired von Willebrand syndrome associated with left ventricular assist device. , 2016, Blood.

[8]  M. Morshuis,et al.  Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. , 2015, Journal of the American College of Cardiology.

[9]  Maria Frigerio,et al.  Low Incidence of Gastrointestinal Bleeding and Pump Thrombosis in Patients Receiving the INCOR LVAD System in the Long-term Follow-up , 2015, The International journal of artificial organs.

[10]  G. Ewald,et al.  The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. , 2015, JACC. Heart failure.

[11]  Lucian Lozonschi,et al.  Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis. , 2015, The Annals of thoracic surgery.

[12]  Myron N. Chang,et al.  The Incidence, Predictors and Outcomes of Gastrointestinal Bleeding in Patients with Left Ventricular Assist Device (LVAD) , 2015, Digestive Diseases and Sciences.

[13]  G. Ewald,et al.  Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device. , 2015, JACC. Heart failure.

[14]  A. Guha,et al.  Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management. , 2015, Methodist DeBakey cardiovascular journal.

[15]  Robert J. Huang,et al.  GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. , 2014, Gastrointestinal endoscopy.

[16]  A. Godsey,et al.  Significantly higher rates of gastrointestinal bleeding and thromboembolic events with left ventricular assist devices. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  F. Pagani,et al.  Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  Nir Uriel,et al.  Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  Sean Pinney,et al.  Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  Igor Gregoric,et al.  HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  Yariv N. Marmor,et al.  Readmissions after implantation of axial flow left ventricular assist device. , 2013, Journal of the American College of Cardiology.

[22]  J. Morgan,et al.  Gastrointestinal bleeding with the HeartMate II left ventricular assist device. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  G. Ewald,et al.  Evaluation of GI bleeding after implantation of left ventricular assist device. , 2012, Gastrointestinal endoscopy.

[24]  Priya Sharma,et al.  Incidence and management of gastrointestinal bleeding with continuous flow assist devices. , 2012, The Annals of thoracic surgery.

[25]  N. Smedira,et al.  Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. , 2011, The Annals of thoracic surgery.

[26]  S. Russell,et al.  Bleeding complications and blood product utilization with left ventricular assist device implantation. , 2011, The Annals of thoracic surgery.

[27]  N. Uriel,et al.  Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. , 2010, Journal of the American College of Cardiology.

[28]  L. Dembo,et al.  Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience. , 2010, Artificial organs.

[29]  D. Goldstein,et al.  Increased Incidence of Gastrointestinal Bleeding Following Implantation of the HeartMate II LVAD , 2010, Journal of cardiac surgery.

[30]  Andrew Boyle,et al.  Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. , 2009, The Journal of thoracic and cardiovascular surgery.

[31]  Ernst Wolner,et al.  Platelet dysfunction in outpatients with left ventricular assist devices. , 2009, The Annals of thoracic surgery.

[32]  K. Affeld,et al.  Local glycoprotein IIb/IIIa receptor inhibitor delivery from the pump surface attenuates platelet adhesion in continuous flow ventricular assist devices. , 2008, Artificial organs.

[33]  Y. Misawa,et al.  Platelet damage caused by the centrifugal pump: in vitro evaluation by measuring the release of alpha-granule packing proteins. , 2008, Artificial organs.

[34]  M. Cappell,et al.  Cessation of recurrent bleeding from gastrointestinal angiodysplasias after aortic valve replacement. , 1986, Annals of internal medicine.

[35]  R. Clouse,et al.  Upper gastrointestinal bleeding in patients with chronic renal failure. , 1985, Annals of internal medicine.